Direxion Daily Biotech Top 5 Bull 2X ETF (TBXU)
| Assets | $3.33M |
| Expense Ratio | 0.97% |
| PE Ratio | n/a |
| Shares Out | 100,001 |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| Volume | 3,713 |
| Open | 33.78 |
| Previous Close | 33.85 |
| Day's Range | 33.63 - 33.89 |
| 52-Week Low | 25.71 |
| 52-Week High | 38.89 |
| Beta | n/a |
| Holdings | 11 |
| Inception Date | Oct 1, 2025 |
About TBXU
Fund Home PageThe Direxion Daily Biotech Top 5 Bull 2X ETF (TBXU) is an exchange-traded fund that mostly invests in health care equity. TBXUis passively managed, providing 2x leveraged exposure to an equally-weighted index of the top 5 largest US companies in thebiotechnologysub-industry. TBXU was launched on Oct 1, 2025 and is issued by Direxion.
Top 10 Holdings
107.86% of assets| Name | Symbol | Weight |
|---|---|---|
| Goldman Finl Sq Trsry Inst 506 | n/a | 22.45% |
| Dreyfus Govt Cash Man Ins | n/a | 17.19% |
| Regeneron Pharmaceuticals, Inc. | REGN | 12.37% |
| Dx D Biotech T 5 Bull 2x Etf Swap | n/a | 11.34% |
| Amgen Inc. | AMGN | 10.86% |
| Gilead Sciences, Inc. | GILD | 9.77% |
| Vertex Pharmaceuticals Incorporated | VRTX | 9.60% |
| Alnylam Pharmaceuticals, Inc. | ALNY | 8.12% |
| Cash | n/a | 4.61% |
| Dx D Biotech T 5 Bull 2x Etf Swap | n/a | 1.55% |
Performance
News
New FDA Director Could Sway Biotech ETFs
Biotech stocks could sway toward the upside with the appointment of a new director at the Federal Drug Administration's Center for Drug Evaluation and Research. Dr. Richard Pazdur will take the reigns...
Trade Top 5 Industry Leaders With Direxion's New Titans ETFs
Direxion expanded its existing product lineup of leveraged and inverse exchange-traded funds (ETFs) with a new suite: the Titans Leveraged & Inverse ETFs. The funds offer a middle-ground approach that...
Trade the Titans: Direxion Debuts New Suite of Leveraged & Inverse ETFs
New York, United States, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Direxion, a leading provider of tactical ETFs, today announced the launch of the Direxion Titans Leveraged & Inverse ETFs, a new suite of fun...